Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 125.38 USD -1.78%
Market Cap: 7.7B USD
Have any thoughts about
Jazz Pharmaceuticals PLC?
Write Note

Jazz Pharmaceuticals PLC
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jazz Pharmaceuticals PLC
Income from Continuing Operations Peer Comparison

Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Income from Continuing Operations
$465.3m
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
31%
Perrigo Company PLC
NYSE:PRGO
Income from Continuing Operations
-$146.9m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Income from Continuing Operations
-$106.2m
CAGR 3-Years
-24%
CAGR 5-Years
-1%
CAGR 10-Years
-7%
G
GH Research PLC
NASDAQ:GHRS
Income from Continuing Operations
-$35.6m
CAGR 3-Years
-329%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Income from Continuing Operations
€75.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Ovoca Bio PLC
LSE:OVB
Income from Continuing Operations
-€4m
CAGR 3-Years
-5%
CAGR 5-Years
-15%
CAGR 10-Years
7%

See Also

What is Jazz Pharmaceuticals PLC's Income from Continuing Operations?
Income from Continuing Operations
465.3m USD

Based on the financial report for Sep 30, 2024, Jazz Pharmaceuticals PLC's Income from Continuing Operations amounts to 465.3m USD.

What is Jazz Pharmaceuticals PLC's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
31%

Over the last year, the Income from Continuing Operations growth was 459%.

Back to Top